• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低试验的环境影响:CRASH-1 与 CRASH-2 临床试验的碳足迹比较。

Reducing the environmental impact of trials: a comparison of the carbon footprint of the CRASH-1 and CRASH-2 clinical trials.

机构信息

Public Health and Environment, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.

出版信息

Trials. 2011 Feb 3;12:31. doi: 10.1186/1745-6215-12-31.

DOI:10.1186/1745-6215-12-31
PMID:21291517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3045899/
Abstract

BACKGROUND

All sectors of the economy, including the health research sector, must reduce their carbon emissions. The UK National Institute for Health Research has recently prepared guidelines on how to minimize the carbon footprint of research. We compare the carbon emissions from two international clinical trials in order to identify where emissions reductions can be made.

METHODS

We conducted a carbon audit of two clinical trials (the CRASH-1 and CRASH-2 trials), quantifying the carbon dioxide emissions produced over a one-year audit period. Carbon emissions arising from the coordination centre, freight delivery, trial-related travel and commuting were calculated and compared.

RESULTS

The total emissions in carbon dioxide equivalents during the one-year audit period were 181.3 tonnes for CRASH-1 and 108.2 tonnes for CRASH-2. In total, CRASH-1 emitted 924.6 tonnes of carbon dioxide equivalents compared with 508.5 tonnes for CRASH-2. The CRASH-1 trial recruited 10,008 patients over 5.1 years, corresponding to 92 kg of carbon dioxide per randomized patient. The CRASH-2 trial recruited 20,211 patients over 4.7 years, corresponding to 25 kg of carbon dioxide per randomized patient. The largest contributor to emissions in CRASH-1 was freight delivery of trial materials (86.0 tonnes, 48% of total emissions), whereas the largest contributor in CRASH-2 was energy use by the trial coordination centre (54.6 tonnes, 30% of total emissions).

CONCLUSIONS

Faster patient recruitment in the CRASH-2 trial largely accounted for its greatly increased carbon efficiency in terms of emissions per randomized patient. Lighter trial materials and web-based data entry also contributed to the overall lower carbon emissions in CRASH-2 as compared to CRASH-1.

TRIAL REGISTRATION NUMBERS

CRASH-1: ISRCTN74459797CRASH-2: ISRCTN86750102.

摘要

背景

包括卫生研究部门在内的所有经济领域都必须减少碳排放。英国国家卫生研究院最近制定了如何将研究的碳足迹最小化的指南。我们比较了两项国际临床试验的碳排放量,以确定可以在何处减少排放量。

方法

我们对两项临床试验(CRASH-1 和 CRASH-2 试验)进行了碳审计,量化了在一年审计期间产生的二氧化碳排放量。计算并比较了协调中心、货运、与试验相关的旅行和通勤产生的碳排放。

结果

在一年的审计期间,CRASH-1 的二氧化碳当量总排放量为 181.3 吨,CRASH-2 为 108.2 吨。总的来说,CRASH-1 排放了 924.6 吨二氧化碳当量,而 CRASH-2 为 508.5 吨。CRASH-1 试验在 5.1 年内招募了 10008 名患者,相当于每位随机患者 92 公斤二氧化碳。CRASH-2 试验在 4.7 年内招募了 20211 名患者,相当于每位随机患者 25 公斤二氧化碳。CRASH-1 试验中排放量最大的是试验材料的货运(86.0 吨,占总排放量的 48%),而 CRASH-2 试验中排放量最大的是试验协调中心的能源使用(54.6 吨,占总排放量的 30%)。

结论

CRASH-2 试验中更快的患者招募在每位随机患者的排放方面大大提高了其碳效率。较轻的试验材料和基于网络的数据录入也有助于 CRASH-2 相对于 CRASH-1 整体减少碳排放。

临床试验注册号

CRASH-1:ISRCTN74459797CRASH-2:ISRCTN86750102。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/3045899/d4b715660592/1745-6215-12-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/3045899/d4b715660592/1745-6215-12-31-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/3045899/d4b715660592/1745-6215-12-31-1.jpg

相似文献

1
Reducing the environmental impact of trials: a comparison of the carbon footprint of the CRASH-1 and CRASH-2 clinical trials.降低试验的环境影响:CRASH-1 与 CRASH-2 临床试验的碳足迹比较。
Trials. 2011 Feb 3;12:31. doi: 10.1186/1745-6215-12-31.
2
The carbon footprint of a renal service in the United Kingdom.英国肾脏服务的碳足迹。
QJM. 2010 Dec;103(12):965-75. doi: 10.1093/qjmed/hcq150. Epub 2010 Aug 18.
3
Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials.实用随机对照试验的碳成本:试验样本的回顾性分析
BMJ. 2009 Oct 30;339:b4187. doi: 10.1136/bmj.b4187.
4
Climate footprint of industry-sponsored clinical research: an analysis of a phase-1 randomised clinical study and discussion of opportunities to reduce its impact.产业资助临床研究的碳足迹:一项 1 期随机临床试验分析及减少其影响的机会探讨。
BMJ Open. 2024 Jan 11;14(1):e077129. doi: 10.1136/bmjopen-2023-077129.
5
The carbon footprint of cataract surgery.白内障手术的碳足迹。
Eye (Lond). 2013 Apr;27(4):495-501. doi: 10.1038/eye.2013.9. Epub 2013 Feb 22.
6
Carbon footprint of industry-sponsored late-stage clinical trials.产业资助的晚期临床试验的碳足迹。
BMJ Open. 2023 Aug 21;13(8):e072491. doi: 10.1136/bmjopen-2023-072491.
7
Quantifying the carbon footprint of clinical trials: guidance development and case studies.量化临床试验的碳足迹:指南制定和案例研究。
BMJ Open. 2024 Jan 24;14(1):e075755. doi: 10.1136/bmjopen-2023-075755.
8
Carbon footprint of patient journeys through primary care: a mixed methods approach.患者在初级保健中的旅程的碳足迹:一种混合方法。
Br J Gen Pract. 2013 Sep;63(614):e595-603. doi: 10.3399/bjgp13X671579.
9
The carbon footprint of an Australian satellite haemodialysis unit.澳大利亚卫星血液透析单元的碳足迹。
Aust Health Rev. 2013 Jun;37(3):369-74. doi: 10.1071/AH13022.
10
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials.学术临床试验的碳足迹是什么?对 10 项试验热点的研究。
BMJ Open. 2024 Oct 16;14(10):e088600. doi: 10.1136/bmjopen-2024-088600.

引用本文的文献

1
Stepping Stones to Sustainability Within Cancer Clinical Trials in Ireland.爱尔兰癌症临床试验中迈向可持续发展的垫脚石。
Curr Oncol. 2025 Aug 8;32(8):446. doi: 10.3390/curroncol32080446.
2
Carbon footprint of a sample of clinical trials for people with neurological disorders: cross-sectional analysis.针对神经系统疾病患者的临床试验样本的碳足迹:横断面分析
BMJ Open. 2025 Jun 17;15(6):e090419. doi: 10.1136/bmjopen-2024-090419.
3
Integrating Sustainability Pillars Into Trial Design Decision-Making: Results of an International Survey.

本文引用的文献

1
The unintended consequences of clinical trials regulations.临床试验法规的意外后果。
PLoS Med. 2009 Nov;3(11):e1000131. doi: 10.1371/journal.pmed.1000131. Epub 2009 Nov 17.
2
Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials.实用随机对照试验的碳成本:试验样本的回顾性分析
BMJ. 2009 Oct 30;339:b4187. doi: 10.1136/bmj.b4187.
3
Are these data real? Statistical methods for the detection of data fabrication in clinical trials.这些数据是真实的吗?临床试验中数据造假检测的统计方法。
将可持续发展支柱纳入试验设计决策:一项国际调查的结果。
Clin Transl Sci. 2025 May;18(5):e70241. doi: 10.1111/cts.70241.
4
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas.行业赞助的人体临床试验的气候足迹:跨多个阶段和疾病领域的临床试验的生命周期评估。
BMJ Open. 2025 Feb 19;15(2):e085364. doi: 10.1136/bmjopen-2024-085364.
5
(Un)Sustainable Science: Greening Practices in Research, Clinical Microbiology, and Veterinary Laboratories Locally and Globally.(非)可持续科学:本地及全球范围内研究、临床微生物学和兽医实验室的绿色实践
Open Forum Infect Dis. 2025 Jan 10;12(2):ofae677. doi: 10.1093/ofid/ofae677. eCollection 2025 Feb.
6
Viewpoint: a white paper for a greener design, conduct and reporting of clinical trials in respiratory medicine.观点:一份关于呼吸医学临床试验更绿色设计、实施和报告的白皮书。
Eur Respir J. 2025 Apr 3;65(4). doi: 10.1183/13993003.01832-2024. Print 2025 Apr.
7
Imperatives and co-benefits of research into climate change and neurological disease.气候变化与神经疾病研究的当务之急和共同效益
Nat Rev Neurol. 2025 Apr;21(4):216-228. doi: 10.1038/s41582-024-01055-6. Epub 2025 Jan 20.
8
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials.学术临床试验的碳足迹是什么?对 10 项试验热点的研究。
BMJ Open. 2024 Oct 16;14(10):e088600. doi: 10.1136/bmjopen-2024-088600.
9
An urgent call for environmental accountability in nephrology clinical trials.对肾脏病学临床试验中环境责任的紧急呼吁。
Clin Kidney J. 2024 Jun 17;17(8):sfae181. doi: 10.1093/ckj/sfae181. eCollection 2024 Aug.
10
Defending and Defining Environmental Responsibilities for the Health Research Sector.捍卫和界定健康研究领域的环境责任。
Sci Eng Ethics. 2024 Jun 6;30(3):25. doi: 10.1007/s11948-024-00487-z.
BMJ. 2005 Jul 30;331(7511):267-70. doi: 10.1136/bmj.331.7511.267.
4
Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.静脉注射皮质类固醇对10008例有临床显著意义的头部损伤成人14天内死亡的影响(MRC CRASH试验):随机安慰剂对照试验
Lancet. 2004;364(9442):1321-8. doi: 10.1016/S0140-6736(04)17188-2.